Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study

Prostate Specific Antigen (PSA) fails to discriminate between benign prostatic hyperplasia (BPH) and Prostate Cancer (PCa), resulting in large numbers of unnecessary biopsies and missed cancer diagnoses. Nanovesicles called exosomes are directly detectable in patient plasma and here we explore the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Logozzi, Mariantonia, Angelini, Daniela F., Giuliani, Alessandro, Mizzoni, Davide, Di Raimo, Rossella, Maggi, Martina, Gentilucci, Alessandro, Marzio, Vittorio, Salciccia, Stefano, Borsellino, Giovanna, Battistini, Luca, Sciarra, Alessandro, Fais, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826376/
https://www.ncbi.nlm.nih.gov/pubmed/31569672
http://dx.doi.org/10.3390/cancers11101449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826376/
https://www.ncbi.nlm.nih.gov/pubmed/31569672
http://dx.doi.org/10.3390/cancers11101449

Ejemplares similares